Researchers at City of Hope have been awarded $32.3 million from the California Institute for Regenerative Medicine (CIRM) to support three novel Phase 1 clinical trials evaluating innovative cell and...

Glioblastoma is a virtually incurable brain cancer with a five-year-survival rate of only 10%.    “It’s heartbreaking to keep telling people in clinic that we don’t have a cure,” said...

Expanding Our ReachIn 2022, City of Hope expanded our reach nationally by acquiring Cancer Treatment Centers of America (CTCA), a network of oncology hospitals and outpatient care centers across...

City of Hope is a leader in the field of stem cell and regenerative medicine — the use of self-renewing cells to treat human disease — and its Alpha Stem...

CONTACT Letisia Marquez 626-476-7593 lemarquez@coh.org   Chimeric antigen receptor (CAR)-NK cell therapy to treat the virus is one of more than two dozen COVID-19 research projects underway   DUARTE, Calif...

John Zaia, M.D. The California Institute for Regenerative Medicine (CIRM) awarded $750,000 to City of Hope’s John Zaia, M.D., for a clinical study on the use of blood plasma as a...

City of Hope’s Department of Stem Cell Biology and Regenerative Medicine has received a $4.9 million grant to train the next generation of scientific leaders in basic stem cell research and its translation into novel, lifesaving treatments...

Pediatric brain tumors are the most common solid tumors in children and the most common cause of childhood death from cancer. While there are effective therapies for some brain tumors...

 CONTACTZen Vuong626-409-9367zvuong@coh.org LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States and a leading research...